Skip to content

Clinical trials

Phase 2 Lymphoma, Large B-Cell, Diffuse trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 2 Country / region: South Korea Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20092
20102
20111
20121
20131
20154
20172
20181
20191
20224
20231
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status6
Active, not recruiting5
Recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Samsung Medical Center3
Asan Medical Center2
Chonnam National University Hospital2
Genmab2
Seoul National University Hospital2
Allogene Therapeutics1
AstraZeneca1
Bayer1
Chonbuk National University Hospital1
Cothera Bioscience, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse26
Lymphoma, Non-Hodgkin6
Recurrence6
Lymphoma, B-Cell3
Lymphoma, Follicular3
Lymphoma, Mantle-Cell3
Lymphoma2
Burkitt Lymphoma1
Cytokine Release Syndrome1
Leukemia, Hairy Cell1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.